Vogenx's IPO
Listed Aug 12, 2026 at $13 on Nasdaq as VOGX.
Breakaway does the work for you: insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.
What does Vogenx do?
“We are a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis.”
| Fact | Vogenx |
|---|---|
| Founded | 2021 |
| Incorporated | Delaware, 2021 |
| Headquarters | Raleigh, North Carolina |
| Website | vogenx.com |
What is the offering?
Each figure names the filing it is from and that filing's date. The market cap is Breakaway's arithmetic from the prospectus's share count.
| Fact | Vogenx |
|---|---|
| Shares offered | 6,250,000 |
| Offer price | $13 a share |
| Raised at that price | $81.3 million |
| Underwriters' discount | $5.7 million |
| Underwriters' option | 937,500 more shares |
| Underwriter | Jones |
| Exchange | Nasdaq Capital Market, as VOGX |
What the filing says about its money
| Fact | Vogenx |
|---|---|
| Revenue | None from product sales yet |
| Net loss | $1.4 million, year to December 31, 2025 |
| Cash | $251,000, as of March 31, 2026 |
| Last preferred stock | Series A preferred |
| Raised before the IPO | $11.5 million in private financings |
What risks does Vogenx name first?
- “| We have incurred significant losses since inception.”
- “| We have never generated revenue from product sales and may never become profitable.”
- “| We will need substantial additional funding in addition to the net proceeds we receive from this offering.”
Every date of Vogenx's IPO
| What | Day |
|---|---|
| Registration filed | Jul 15, 2026 |
| Exchange registration filed | Aug 10, 2026 |
| Declared effective by the SEC | Aug 11, 2026 |
| Priced | Aug 11, 2026 |
| First trade | Aug 12, 2026 |
| Lock-up ends | Feb 7, 2027 |
How did its first days trade?
From its daily bars, each close against its $13 offer price.
| Day | Open | Close | From the offer |
|---|---|---|---|
| Aug 12 | $13 | $13 | 0.0% |
| Aug 13 | $13.09 | $14.09 | +8.4% |
| Aug 14 | $14.34 | $14.78 | +13.7% |
| Aug 17 | $14.80 | $15.75 | +21.2% |
| Aug 18 | $18.63 | $19.75 | +51.9% |
The other IPOs expected
| Company | Price |
|---|---|
| $19 to $21 | |
| $15 to $17 | |
| $15 to $17 | |
| $7 | |
| $5 to $7 |
Vogenx IPO questions
When is Vogenx's IPO?
Listed Aug 12, 2026 at $13 on Nasdaq as VOGX.
What is Vogenx's IPO price?
Vogenx's IPO priced at $13 a share, per its final prospectus of Aug 12, 2026.
How many shares is Vogenx selling?
6,250,000 shares, and the underwriters may buy 937,500 more, per its final prospectus (424B4).
Who are the underwriters?
Jones, as the prospectus's cover names them.
When does the lock-up end?
Vogenx's IPO lock-up ends Feb 7, 2027. Its final prospectus says: “.”
Does Breakaway rate Vogenx?
Breakaway scores a new stock from its second trading day, ranked against every US stock it scores. For its first 21 sessions the page says New listing in place of the tier, and each check that needs more history waits for it.
Can Breakaway say where Vogenx's price will go?
No. Breakaway does not say where a price will go. Every figure here is from the company's SEC filings, linked on each line.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every new listing, ranked live, free. No account.
See all 16 new listings rankedSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.